Arginine stimulates a hormone linked to the treatment of type 2 diabetes.
More than 371 million people worldwide suffer from diabetes, of whom 90 percent are affected by lifestyle-related diabetes mellitus type 2 (type 2 diabetes). In new experiments, researchers from the University of Copenhagen working in collaboration with a research group at the University of Cincinnati, USA, have demonstrated that the amino acid arginine improves glucose metabolism significantly in both lean (insulin-sensitive) and obese (insulin-resistant) mice.
Postdoc Christoffer Clemmensen said that the amino acid is just as effective as several well-established drugs for type 2 diabetics.
Clemmensen said that the team have demonstrated that both lean and fat laboratory mice benefit considerably from arginine supplements.
He said that they improved glucose metabolism by as much as 40 percent in both groups and can also see that arginine increases the body's production of glucagon-like peptide-1 (GLP-1), an intestinal hormone which plays an important role in regulating appetite and glucose metabolism.
The findings have been published in the scientific journal Endocrinology.